Simple jQuery Dropdowns

Browsing by Author Cliniques Universitaires Saint-Luc, Brussels

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)
20-Jan-2018Phase II study of BGJ398 in patients with FGFR-Altered advanced cholangiocarcinomaMilind Javle; Maeve Lowery; Rachna T. Shroff; Karl Heinz Weiss; Christoph Springfeld; Mitesh J. Borad; Ramesh K. Ramanathan; Lipika Goyal; Saeed Sadeghi; Teresa Macarulla; Anthony El-Khoueiry; Robin Kate Kelley; Ivan Borbath; Su Pin Choo; Do Youn Oh; Philip A. Philip; Li Tzong Chen; Thanyanan Reungwetwattana; Eric Van Cutsem; Kun Huei Yeh; Kristen Ciombor; Richard S. Finn; Anuradha Patel; Suman Sen; Dale Porter; Randi Isaacs; Andrew X. Zhu; Ghassan K. Abou-Alfa; Tanios Bekaii-Saab; National Cheng Kung University Hospital; Barbara Ann Karmanos Cancer Institute; National Cancer Centre, Singapore; KU Leuven– University Hospital Leuven; UCSF Helen Diller Family Comprehensive Cancer Center; Mayo Clinic Scottsdale-Phoenix, Arizona; National Taiwan University College of Medicine; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Keck School of Medicine of USC; University of Texas MD Anderson Cancer Center; Seoul National University; Cliniques Universitaires Saint-Luc, Brussels; Hospital Universitari Vall d'Hebron; Memorial Sloan-Kettering Cancer Center; David Geffen School of Medicine at UCLA; Ohio State University; Universitätsklinikum Heidelberg; Massachusetts General Hospital Cancer Center; Novartis Pharmaceuticals Corporation
24-Jan-2014Residual macrovascular risk in 2013: What have we learned?Jean Charles Fruchart; Jean Davignon; Michel P. Hermans; Khalid Al-Rubeaan; Pierre Amarenco; Gerd Assmann; Philip Barter; John Betteridge; Eric Bruckert; Ada Cuevas; Michel Farnier; Ele Ferrannini; Paola Fioretto; Jacques Genest; Henry N. Ginsberg; Antonio M. Gotto; Dayi Hu; Takashi Kadowaki; Tatsuhiko Kodama; Michel Krempf; Yuji Matsuzawa; Jesús M. Núñez-Cortés; Carlos C. Monfil; Hisao Ogawa; Jorge Plutzky; Daniel J. Rader; Shaukat Sadikot; Raul D. Santos; Evgeny Shlyakhto; Piyamitr Sritara; Rody Sy; Alan Tall; Chee E. Tan; Lale Tokgözoǧlu; Peter P. Toth; Paul Valensi; Christoph Wanner; Alberto Zambon; Junren Zhu; Paul Zimmet; R3i Foundation; Fondation coeur et arteres; Institut de Recherches Cliniques de Montreal; Cliniques Universitaires Saint-Luc, Brussels; King Saud University; Hopital Bichat-Claude-Bernard AP-HP; Assmann-Stiftung für Prävention; University of New South Wales (UNSW) Australia; UCL; Hopital Universitaire Pitie Salpetriere; Clinica Las Condes; Point Medical; Universita di Pisa; Universita degli Studi di Padova; McGill University Health Centre, Royal Victoria Hospital; Columbia University in the City of New York; Weill Cornell Medical College; Peking University; University of Tokyo; Centre Hospitalier Universitaire de Nantes; Osaka University; Hospital General Universitario Gregorio Maranon; University of Concepcion; Kumamoto University; Brigham and Women's Hospital and Harvard Medical School; Penn Cardiovascular Institute; Jaslok Hospital and Research Centre; Instituto do Coracao do Hospital das Clinicas; Almazov National Medical Research Centre; Mahidol University; University of the Philippines Manila; Columbia University, College of Physicians and Surgeons; Gleneagles Hospital; Hacettepe Universitesi; University of Illinois; Universite Paris 13; Universitatsklinikum Wurzburg; Fudan University; Baker Heart and Diabetes Institute
12-Dec-2007Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: A randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudinePierre Vandepapelière; George K.K. Lau; Geert Leroux-Roels; Yves Horsmans; Edward Gane; Tawesak Tawandee; Mohd Ismail bin Merican; Khin Maung Win; Christian Trepo; Graham Cooksley; Martine Wettendorff; Carlo Ferrari; Queen Mary Hospital Hong Kong; Universiteit Gent; Cliniques Universitaires Saint-Luc, Brussels; Middlemore Hospital, Auckland; Mahidol University; Kuala Lumpur Hospital; Yangon General Hospital; Hopital de l'Hotel-Dieu CHU Lyon; University of Queensland; Glaxosmithkline Biologicals S.A.; Universita degli Studi di Parma